GeNeuro wins European patent for ALS drug candidate GNK-301

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. TLT
7. BETR
8. AMZN
9. LEN
10. APO

Go back to GeNeuro wins European patent for ALS drug candidate GNK-301
(NASDAQ: NRXP) Delayed: 3.41 +0.06 (1.79%)
Previous Close $3.35    52 Week High $ 
Open $3.38    52 Week Low $ 
Day High $3.49    P/E N/A 
Day Low $3.36    EPS $ 
Volume 204,747